Haleon plc (HLN) Stock Grade

About Haleon plc's fundamentals

Haleon is a large-cap healthcare company with a market capitalization of $44.2 billion that generated a net margin of 14.8%, indicating solid profitability on its revenue base. However, the company faced a headwind with revenue declining 1.8% year-over-year, suggesting challenges in maintaining growth momentum. Trading at a P/E ratio of 20.6, the company offers a 3.2% dividend yield while generating a return on equity of 9.9%, reflecting moderate efficiency in deploying shareholder capital.